Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Phathom Pharmaceuticals, Inc. (PHAT) had Revenue of $74.27M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$74.27M
Net Income	$-17.58M
Cost of Goods Sold	$15.10M
Gross Profit	$59.18M
Operating Expenses	$78.24M
Operating Income	$-3.96M
Non-Operating Income/Expense	$-13.62M
Pre-Tax Income	$-17.58M
Normalized Pre-Tax Income	$-17.58M
Income after Taxes	$-17.58M
Income from Continuous Operations	$-17.58M
Consolidated Net Income/Loss	$-17.58M
Normalized Income after Taxes	$-17.58M
EBIT	$-3.96M
EBITDA	$-2.94M
Weighted-Average Shares Outstanding (Basic)	83.75M
Weighted-Average Shares Outstanding (Diluted)	83.75M
Earnings per Share (EPS) (Basic)	$-0.21
Earnings per Share (EPS) (Diluted)	$-0.21
Balance Sheet Financials
Current Assets	$295.92M
Property, Plant, and Equipment	$0.97M
Long-Term Assets	$31.16M
Total Assets	$327.07M
Current Liabilities	$153.78M
Long-Term Debt	$164.59M
Long-Term Liabilities	$517.57M
Total Liabilities	$671.35M
Common Equity	$-344.27M
Tangible Shareholders Equity	$-344.27M
Shareholders Equity	$-344.27M
Common Shares Outstanding	80.07M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-17.58M
Cash Flow from Investing Activities	$-0.10M
Cash Flow from Financial Activities	$70.19M
Beginning Cash	$132.83M
End Cash	$185.34M
Increase/Decrease in Cash	$52.51M
Stock-Based Compensation	$12.25M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.92
Debt to Equity Ratio	-0.48
Gross Margin	79.68%
Operating Margin	-5.34%
EBIT Margin	-5.34%
EBITDA Margin	--
Pre-Tax Profit Margin	-23.67%
Profit Margin	-23.67%
Free Cash Flow	$-17.68M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.23
Inventory Turnover	1.96
Receiveable Turnover	0.76
Days Sales in Receivables	118.05
Return on Equity	5.11%
Return on Tangible Equity	5.11%
Return on Assets	-5.38%
Return on Investments	9.78%
Book Value Per Share	$-4.30
Free Cash Flow per Share	$-0.21
Operating Cash Flow per Share	$-0.21

Data from Zacks Investment Research, Inc.